DAFTAR PUSTAKA

1. Bart M, Harris S R, Advani A, et al. (2014) Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination. mBio 5(2): e01074-142. Cherry J D (2010). The Present and Future Control of Pertussis. CID: 51(6): 663-6673. Correspondence (2013) Pertactin-Negative Variants of Bordetella pertussis in the United State. NEJM: 368(6)4.Kapasi A, Meade B D, Plikaytis B, et al. (2012) Comparative Study of Different Sources of Pertussis Toxin (PT) as Coating Antigens in IgG Anti-PT Enzyme-Linked Immunosorbent Assays dalam Clinical and Vaccine Immunology. ASM: 19(1): 64-725. Menzies S L, Kadwad V, Pawloski L C, et al. (2009) Development and Analytical Validation of an Immunoassay for Quantifying Serum Anti-Pertuss is Toxin Antybodies Resulting from Bordetella pertussis Infection dalam Clinical and Vaccine Immunology. ASM: 16(12): 17816. Rodgers L, Martin S W, Cohn A, et al. (2013) Epidemiology and Laboratory Feature of Large Outbreak of Pertussis-Like Illnesses Associated with Cocirculating Bordetella holmessi and Bordetella pertussis- Ohio, 2010-2011. CID: 567. Tatti K M, Sparks K N, Boney K O, et al. (2011) Novel Multitarget Real-Time PCR Assay for Rapid Detection of Bordetella Species in Clinical Specimens. Journal of Clinical Microbiology: 49: 4059-40668. Quinn H E, Snelling T L, Macartney K K, et al. (2014) Duration of Protection After First Dose of Acellular Pertussis Vaccine in Infants. Pediatrics: 133: e513